Patient and community preferences for treatments and health states in multiple sclerosis

Lisa A. Prosser, Karen M. Kuntz, Amit Bar-Or, Milton C. Weinstein

Research output: Contribution to journalArticle

39 Scopus citations

Abstract

Objective: To examine preferences for treatments and health states for patients with relapsing-remitting MS and members of the community. Methods: A survey was developed to evaluate health-related quality-of-life measures (utilities) for three treatments and six MS health states using a utility-elicitation software package, U-Titer II. Sixty-two MS patients at two large teaching hospitals in Boston, MA, and 67 members of the general community in San Diego, CA, completed the health-related quality-of-life survey using a computer. Results: Assessment of quality of life decreased as disability level of MS health states increased for both respondent groups. Respondents rated less-disabled health states relatively highly (> 0.94 for patients and > 0.89 for community respondents). Quality-of-life measures for treatments in mean utilities ranged from 0.80 to 0.96. Patients assigned higher utilities for both MS health states and treatment states than community respondents; the ratings became more disparate as health states worsened. Conclusions: On average, respondents assigned utilities to currently available treatments for MS that are comparable to those of mild to moderate stages of the disease itself. These results underscore the importance of including preferences for health states and treatment alternatives in the decision to initiate treatment for individual patients or in the evaluation of effectiveness or cost-effectiveness of these treatments in patients with MS.

Original languageEnglish (US)
Pages (from-to)311-319
Number of pages9
JournalMultiple Sclerosis
Volume9
Issue number3
DOIs
StatePublished - Jun 1 2003
Externally publishedYes

Keywords

  • Multiple sclerosis
  • Patient preferences
  • Quality of life
  • Utility

Fingerprint Dive into the research topics of 'Patient and community preferences for treatments and health states in multiple sclerosis'. Together they form a unique fingerprint.

  • Cite this